|
Status |
Public on May 05, 2022 |
Title |
AML patient #116 treated with induction Induction chemotherapy, CD8 cells |
Sample type |
RNA |
|
|
Source name |
AML patient
|
Organism |
Homo sapiens |
Characteristics |
disease state: AML tissue: peripheral blood (PB) cell type: CD8+ T cells treatment: Induction chemotherapy only pairs: 6
|
Treatment protocol |
PBMCs were first separated by T-cell negative selection with a custom made kit (Stem Cell Technologies) containing Abs against CD33, CD34, CD123, CD11c, and CD36. CD3+ CD4+ and CD3+CD8+ T cells were then sorted on a FACSAria II (BSL-2) (BD) to high purity (>98%)
|
Extracted molecule |
total RNA |
Extraction protocol |
Total RNA was isolated using TRIzol (Life Techologies) and purified using the RNA Clean&Concentrator Kit (Zymo Research). Sample quality was checked using the Agilent Bioanalyzer Nano kit, and concentrations were verified using the Nanodrop spectrophotometer (Thermo Fisher Scientific). Only specimens with a high RNA integrity (RIN >9) were used for analyses.
|
Label |
biotin
|
Label protocol |
Total RNA was amplified with the NuGEN™ Ovation Pico WTA system and biotin labelled according manufacturer’s instructions (Affymetrix)
|
|
|
Hybridization protocol |
Hybridization with Human PrimeView expression arrays (Affymetrix) as per manufacturer’s instructions.
|
Scan protocol |
Scanning was performed with M10 scanner using AGCC ScanCom software.
|
Description |
Gene expression data from AML patient treated with induction Induction chemotherapytherapy of CD8+ T cells in the peripheral blood (PB) at early lymphocyte recovery (ELR) C_ELR_6_CD8
|
Data processing |
R/Bioconductor package 'affy' and RMA for background processing (PM-MM model), quantile normalization, probe summarization
|
|
|
Submission date |
May 06, 2019 |
Last update date |
May 05, 2022 |
Contact name |
Hanna A Knaus |
Organization name |
Johns Hopkins
|
Department |
Oncology
|
Lab |
Luznik Lab
|
Street address |
1650 Orleans St
|
City |
Baltimore |
State/province |
Maryland |
ZIP/Postal code |
21231 |
Country |
USA |
|
|
Platform ID |
GPL16043 |
Series (1) |
GSE130753 |
Expression profiling of CD4+and CD8+ T cells in peripheral blood (PB) of AML patients who were treated with induction chemotherapy plus pomalidomide |
|